去年，IDEXX实验室表现最佳的业务板块CAG Diagnostics recurring revenue实现营收3.41B美元。United States的营收贡献最高，去年达到2.75B美元。最近一个季度，截至2026-06-30，IDEXX实验室表现最佳的业务板块CAG Diagnostics recurring revenue实现营收974.71M美元。United States的营收贡献最高，达到772.97M美元。

业务

营业收入

占比

年报

年报

单季报

CAG Diagnostics recurring revenue

IDEXX VetLab consumables

Reference laboratory diagnostic and consulting services

Rapid assay products

CAG Diagnostics capital - instruments

Veterinary software, services and diagnostic imaging systems

CAG Diagnostics services and accessories

Other

CAG

Water

LPD

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

CAG Diagnostics recurring revenue

3.41B(46.18%)

3.13B(46.57%)

2.94B(46.55%)

2.66B(46.27%)

2.53B(46.36%)

2.11B(46.50%)

--(--)

IDEXX VetLab consumables

1.50B(20.29%)

1.30B(19.39%)

1.19B(18.84%)

1.06B(18.39%)

1.01B(18.41%)

824.38M(18.13%)

--(--)

Reference laboratory diagnostic and consulting services

1.42B(19.30%)

1.34B(19.88%)

1.28B(20.27%)

1.18B(20.49%)

1.12B(20.55%)

946.27M(20.82%)

--(--)

Rapid assay products

348.95M(4.73%)

359.75M(5.35%)

344.49M(5.46%)

313.67M(5.46%)

296.85M(5.43%)

253.02M(5.57%)

--(--)

CAG Diagnostics capital - instruments

345.88M(4.69%)

312.62M(4.65%)

279.33M(4.43%)

251.19M(4.37%)

206.26M(3.77%)

162.98M(3.59%)

--(--)

Veterinary software, services and diagnostic imaging systems

200.21M(2.71%)

131.93M(1.96%)

137.60M(2.18%)

147.33M(2.56%)

149.14M(2.73%)

108.95M(2.40%)

--(--)

CAG Diagnostics services and accessories

137.42M(1.86%)

130.37M(1.94%)

124.05M(1.97%)

111.26M(1.94%)

107.27M(1.96%)

90.18M(1.98%)

--(--)

Other

17.48M(0.24%)

16.29M(0.24%)

18.79M(0.30%)

30.20M(0.53%)

43.01M(0.79%)

46.42M(1.02%)

22.24M(0.92%)

22.04M(1.00%)

CAG

--(--)

2.12B(88.05%)

1.94B(87.45%)

Water

--(--)

132.85M(5.52%)

125.20M(5.66%)

LPD

--(--)

132.63M(5.51%)

130.58M(5.90%)

地区

营业收入

占比

年报

年报

单季报

United States

Other Euorpe

Germany

Canada

United Kingdom

France

Asia Pacific Region-Other

Australia

Latin America

Japan

Spain (Country)

Italy (Country)

Switzerland

Netherlands

China (Country)

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

United States

2.75B(63.96%)

2.53B(64.99%)

2.39B(65.32%)

2.18B(64.83%)

2.00B(62.07%)

1.69B(62.48%)

1.50B(62.13%)

Other Euorpe

230.03M(5.34%)

196.31M(5.04%)

176.40M(4.82%)

161.58M(4.80%)

167.53M(5.21%)

148.05M(5.47%)

122.21M(5.08%)

Germany

206.76M(4.80%)

173.68M(4.46%)

149.79M(4.09%)

137.88M(4.09%)

146.76M(4.56%)

119.35M(4.41%)

104.08M(4.32%)

Canada

167.32M(3.89%)

152.88M(3.92%)

150.11M(4.10%)

142.74M(4.24%)

139.73M(4.35%)

107.40M(3.97%)

99.55M(4.14%)

United Kingdom

154.44M(3.59%)

134.63M(3.45%)

121.75M(3.33%)

110.40M(3.28%)

114.95M(3.58%)

90.16M(3.33%)

90.97M(3.78%)

France

126.00M(2.93%)

110.80M(2.84%)

96.80M(2.64%)

84.48M(2.51%)

90.84M(2.83%)

74.81M(2.76%)

64.77M(2.69%)

Asia Pacific Region-Other

124.36M(2.89%)

110.10M(2.82%)

104.11M(2.84%)

96.29M(2.86%)

89.52M(2.78%)

68.21M(2.52%)

61.05M(2.54%)

Australia

112.25M(2.61%)

101.96M(2.62%)

95.47M(2.61%)

96.41M(2.86%)

94.41M(2.94%)

79.63M(2.94%)

71.07M(2.95%)

Latin America

90.41M(2.10%)

83.69M(2.15%)

83.92M(2.29%)

75.03M(2.23%)

66.62M(2.07%)

51.86M(1.92%)

56.52M(2.35%)

Japan

83.36M(1.94%)

73.14M(1.88%)

75.57M(2.06%)

77.66M(2.31%)

84.28M(2.62%)

74.72M(2.76%)

67.25M(2.79%)

Spain (Country)

70.97M(1.65%)

61.86M(1.59%)

52.33M(1.43%)

46.98M(1.40%)

48.17M(1.50%)

39.27M(1.45%)

36.44M(1.51%)

Italy (Country)

66.86M(1.55%)

58.22M(1.49%)

53.79M(1.47%)

48.19M(1.43%)

52.06M(1.62%)

42.82M(1.58%)

39.73M(1.65%)

Switzerland

41.70M(0.97%)

37.18M(0.95%)

34.83M(0.95%)

30.65M(0.91%)

31.98M(0.99%)

24.85M(0.92%)

20.86M(0.87%)

Netherlands

40.50M(0.94%)

34.05M(0.87%)

30.51M(0.83%)

26.88M(0.80%)

29.66M(0.92%)

23.46M(0.87%)

19.40M(0.81%)

China (Country)

35.96M(0.84%)

35.82M(0.92%)

44.17M(1.21%)

49.19M(1.46%)

63.17M(1.96%)

70.84M(2.62%)

57.52M(2.39%)